Moreover, AgRP can simultaneously induce or block different signaling pathways and newly developed biased MC4R ligands were applied as an anti-obesity treatment (19, 49, 50). This evidence concerns the gene MC4R and obesity due to melanocortin 4 receptor deficiency.